Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial save search
KalVista Pharmaceuticals Announces Initiation of KVD900 Phase 3 KONFIDENT Clinical Trial
Published: 2022-03-07 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -2.65%
H: 0.0%
C: 0.0%
kvd900 als trial phase 3
Albemarle Corporation to Present at 2022 J.P. Morgan Industrials Conference
Published: 2022-03-07 (Crawled : 12:00) - prnewswire.com
ALB | $112.15 0.31% -0.13% 2M
|
Process Industries
|
| O: -1.07%
H: 0.68%
C: -4.7%
ema als trials trial conference corporation
AAON to Present at J.P. Morgan Industrials Conference
Published: 2022-03-04 (Crawled : 18:00) - globenewswire.com
AAON | $85.45 0.25% 0.25% 490K
|
Producer Manufacturing
|
| O: -1.58%
H: 0.0%
C: 0.0%
als trials trial conference
Global Connected Consumer, Enterprise, and Industrial IoT Device Market Report 2022-2027: Device Ecosystem, Technology Enablers, Company Analysis, Future of Smart and Connected Devices
Published: 2022-03-04 (Crawled : 15:30) - prnewswire.com
LNVGF | News | $1.1 -28.71% 1K
|
Electronic Technology
|
| O: -2.84%
H: 0.0%
C: -2.9%
LNVGY | News | $20.78 -0.43% 41K
|
Manufacturing
|
| O: -4.37%
H: 0.0%
C: -2.33%
NOKBF | News | $3.38 -2.55% 1.5K
|
Electronic Technology
|
| O: -6.76%
H: 3.44%
C: 3.44%
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: -5.77%
H: 1.36%
C: -5.59%
TCLRY | $0.001 1000.0% 140K
|
Manufacturing
|
| O: -0.69%
H: 0.8%
C: 0.8%
WHR | News A | $104.67 0.54% 0.0% 1M
|
Consumer Durables
|
| O: -1.13%
H: 0.0%
C: 0.0%
ORCL | $114.88 -0.97% 0.01% 8.2M
|
Technology Services
|
| O: -1.26%
H: 0.0%
C: 0.0%
NOK | News | $3.52 2.03% 0.0% 17M
|
Electronic Technology
|
| O: -7.49%
H: 0.0%
C: 0.0%
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: -2.27%
H: 0.0%
C: 0.0%
DELL | News | $114.87 -2.96% -0.09% 9.4M
|
Electronic Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: -5.43%
H: 0.0%
C: 0.0%
VUZI P | $1.19 -5.56% -5.88% 550K
|
Electronic Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
POOL | News | $361.21 -0.47% -0.47% 330K
|
Distribution Services
|
| O: -0.34%
H: 0.0%
C: 0.0%
MSFT | News F | $399.09 -1.28% -1.3% 29M
|
Technology Services
|
| O: -2.83%
H: 0.0%
C: 0.0%
AAPL | News S | $164.96 -1.24% -1.32% 67M
|
Electronic Technology
|
| O: -2.32%
H: 0.0%
C: 0.0%
ces ce mark device technology trial system report smart iot
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Telefonaktiebolaget LM Ericsson (ERIC) For Possible Securities Law Violations, Investors With Significant Losses Encouraged to Contact Firm
Published: 2022-03-04 (Crawled : 15:00) - prnewswire.com
ERIC | News | $5.1 0.79% 0.78% 19M
|
Electronic Technology
|
| O: -1.52%
H: 0.0%
C: 0.0%
pos trial
First Industrial Realty Trust to Present at Citi's 2022 Global Property CEO Conference
Published: 2022-03-04 (Crawled : 14:30) - prnewswire.com
FR | $45.63 -0.96% 0.0% 2.1M
|
Finance
|
| O: -1.02%
H: 0.0%
C: 0.0%
ceo trial conference trust
Johnson Controls to present at the 2022 J.P. Morgan Industrials Conference
Published: 2022-03-04 (Crawled : 13:00) - prnewswire.com
JCI | News | $63.66 -0.17% 0.0% 5.2M
|
Producer Manufacturing
|
| O: -2.09%
H: 0.0%
C: 0.0%
als control trials trial conference
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the American Academy of Neurology Annual Meeting
Published: 2022-03-04 (Crawled : 13:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -11.07%
H: 0.0%
C: 0.0%
america multiple sclerosis als trials trial therapeutics presentation sclerosis phase 3
Watsco to Present at the J.P. Morgan Industrials Conference on March 17, 2022
Published: 2022-03-04 (Crawled : 13:00) - globenewswire.com
WSO | $396.92 -1.25% 0.0% 340K
|
Producer Manufacturing
|
| O: -0.58%
H: 0.0%
C: 0.0%
als trials trial conference
GRAB INVESTIGATION: Hagens Berman, National Trial Attorneys, Investigating Grab Holdings Limited (GRAB) For Possible Securities Law Violations, Investors With Significant Losses Encouraged to Contact Firm
Published: 2022-03-04 (Crawled : 12:00) - prnewswire.com
GRAB | $3.36 -0.89% -0.89% 18M
|
n/a
|
| O: 9.45%
H: 16.43%
C: -6.41%
trial
Evofem Completes Enrollment in EVOGUARD Phase 3 Clinical Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women
Published: 2022-03-04 (Crawled : 12:00) - prnewswire.com
EVFM | $0.0141 -16.94% 180K
|
Health Technology
|
| O: -9.41%
H: 0.0%
C: 0.0%
evo100 trial 100 women phase 3 enroll
American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
Published: 2022-03-04 (Crawled : 12:00) - biospace.com/
CRYO | $0.0001 0.0% 19K
|
Information
|
| O: 0.14%
H: 0.0%
C: -11.9%
america treatment trial cryo syndros
CNH Industrial donates $500,000 to support Ukrainians in need
Published: 2022-03-04 (Crawled : 10:00) - globenewswire.com
CNHI | $12.31 -0.73% 0.0% 6.9M
|
Producer Manufacturing
|
| O: -6.59%
H: 0.0%
C: 0.0%
500 trial
High-Power Semiconductor Wafer Probing System for Automotive, Renewable Energy, and Industrial Applications
Published: 2022-03-03 (Crawled : 22:00) - formfactor.com
FORM | $40.75 -3.18% -3.29% 570K
|
Electronic Technology
|
| O: -1.48%
H: 1.35%
C: -1.02%
semiconductor renewable application automotive trial system energy
Kennametal to Attend Bank of America Global Industrials Conference 2022
Published: 2022-03-03 (Crawled : 22:00) - prnewswire.com
KMT | $24.51 1.7% 0.0% 660K
|
Producer Manufacturing
|
| O: -2.02%
H: 1.24%
C: -2.0%
america als trials trial conference
Praluzatamab Ravtansine, a CD166-Targeting Antibody– Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Published: 2022-03-03 (Crawled : 21:00) - cytomx.com
CTMX | $1.67 -3.47% -3.59% 510K
|
Health Technology
|
| O: -1.57%
H: 2.66%
C: -1.33%
cd166 solid tumors cd16 drug trial label antibody
Fulcrum Therapeutics® Announces REACH, a Phase 3 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -1.71%
H: 10.39%
C: 7.24%
therapeutics muscular dystrophy trial phase 3
Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K
|
Transportation and Warehousing
|
| O: 0.0%
H: 7.42%
C: 0.26%
glaucoma drug trial phase 1 bioscience phase 2 phase 3
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent Filings, & AACR Meeting
Published: 2022-03-03 (Crawled : 16:00) - biospace.com/
GLSI | $12.17 -5.59% -5.92% 31K
|
Health Technology
|
| O: 1.09%
H: 2.28%
C: -4.32%
patent trial
Air Products to Highlight Industrial Gases for Improved Plant-based Food Processing at Natural Products Expo West
Published: 2022-03-03 (Crawled : 15:30) - prnewswire.com
APD | $231.64 -0.59% 0.0% 1.7M
|
Process Industries
|
| O: 0.98%
H: 0.06%
C: -1.59%
air trial food
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.